Danielle A Kapustin

Ms. Danielle A Kapustin

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2023 in The Laryngoscope
Verified
Journal Article
Closed access
DKDanielle A Kapustin
Danielle A Kapustin
JYJun Yun
Jun Yun
VSVivian Su
Vivian Su
SRSamuel J. Rubin
Samuel J. Rubin
IMIppolito Modica
Ippolito Modica
MUMark L. Urken
Mark L. Urken

28 February 2023 in Head and Neck Pathology
Verified
Journal Article
Closed access
PDF file
JBJohn E. Beute
John E. Beute
LGLily A. Greenberg
Lily A. Greenberg
LWLauren E. Wein
Lauren E. Wein
DKDanielle A Kapustin
Danielle A Kapustin
JFJun Fan
Jun Fan
MUMark L. Urken
Mark L. Urken

18 April 2023 in Diagnostic Pathology
Verified
Journal Article
Open access
PDF file
GSGabriella T. Seo
Gabriella T. Seo
JMJeremy Minkowitz
Jeremy Minkowitz
DKDanielle A Kapustin
Danielle A Kapustin
JFJun Fan
Jun Fan
GMGerald Minkowitz
Gerald Minkowitz
SFSydney D. Finkelstein
Sydney D. Finkelstein
Background: Struma ovarii is an unusual ovarian teratoma containing predominantly thyroid tissue. Less than 10% of cases undergo malignant transformation in the thyroid tissue and are considered malignant struma ovarii (MSO). MSO have been reported with concurrent thyroid lesions, but molecular data is lacking. Case presentation: A 42-year-old female developed MSO and synchronous multifocal subcentimeter papillary thyroid carcinoma (PTC). The patient underwent a salpingo-oophrectomy, thyroidectomy, and low-dose radioactive iodine ablation. Both the thyroid subcentimeter PTC and MSO were positive for BRAF V600E mutation, and microRNA expression profiles were similar across all tumor deposits. However, only the malignant component demonstrated extensive loss of heterozygosity (LOH) involving multiple tumor suppressor gene (TSG) chromosomal loci. Conclusions: We present the first reported case of MSO with synchronous multifocal subcentimeter PTC in the thyroid containing concordant BRAF V600E mutations and resulting with discordant LOH findings. This data suggests that loss of expression in tumor suppressor gene(s) may be an important contributor to phenotypic expression of malignancy.

7 November 2023 in The Laryngoscope
Verified
Journal Article
Closed access
SGShivee Gilja
Shivee Gilja
AKArvind Kumar
Arvind Kumar
DKDanielle A Kapustin
Danielle A Kapustin
VSVivian Su
Vivian Su
SRSamuel J. Rubin
Samuel J. Rubin
MKMohemmed N. Khan
Mohemmed N. Khan

3 November 2023 in The Laryngoscope
Verified
Journal Article
Closed access
DKDanielle A Kapustin
Danielle A Kapustin
VSVivian Su
Vivian Su
JYJun Yun
Jun Yun
SRSamuel J. Rubin
Samuel J. Rubin
DCDaniel Chung
Daniel Chung
MUMark L. Urken
Mark L. Urken

4 October 2023 in Pathology - Research and Practice
Verified
Journal Article
Closed access
SFSydney Finkelstein
Sydney Finkelstein
VTVenkata Arun Timmaraju
Venkata Arun Timmaraju
SSShabnam Samankan
Shabnam Samankan
QOQuinn O'MAlley
Quinn O'MAlley
DKDanielle A Kapustin
Danielle A Kapustin
MBMargaret S Brandwein-Weber
Margaret S Brandwein-Weber